Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question: December

Staff  |  Issue: December 2012  |  December 1, 2012

Test Your Coding Skills for the Certified Rheumatology Coder Course and Exam

A 60-year-old female with severe rheumatoid arthritis returns for an infliximab infusion. She is currently on methotrexate and prednisone. The patient reports no active infection. She reports the she has tenderness in her right fingers and right knee. The patient’s history is expanded problem focused.

The patient’s weight is 169 pounds, her height is 5 feet 7 inches, and her temperature is 98.7 degrees. The patient is well groomed and appears to be in good spirits. Her heart’s rate and rhythm are within normal limits. Her right hand and right knee have slight tenderness and some swelling. There are no rashes on her head or neck, torso, right upper or lower extremities, or her left upper or lower extremities.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The infusion is started at 1:30 PM. After 35 minutes and 200 mg of infliximab, the patient has an adverse reaction. The infusion is stopped. The patient’s IV is flushed with saline for 32 minutes and diphenhydramine is pushed into the IV to counteract the adverse reaction. The infusion is discontinued and the patient is monitored for 30 minutes. The patient is scheduled for a follow-up visit in a week.

  1. What was the level of medical decision making?
    1. Straightforward
    2. Low
    3. Moderate
    4. High
  2. How is the infliximab infusion coded?
    1. P96365
    2. 96401
    3. 96413
    4. 96415
  3. How is the diphenhydramine push coded?
    1. 96401
    2. 96374
    3. 96375
    4. 96415
  4. How is the saline infusion coded?
    1. 96360
    2. 96360
    3. 96360-59
    4. 96361-59
  5. How many units would be coded for the infliximab?
    1. 60
    2. 600
    3. 20
    4. 200

click here for the answers.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Share: 

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingdruginfliximabMethotrexatePractice Managementprednisonerheumatologist

Related Articles

    Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

    August 16, 2019

    Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…

    Reading Rheum

    July 1, 2007

    Handpicked Reviews of Contemporary Literature

    Coding Corner Question

    July 1, 2010

    July’s Coding Challenge

    Coding Corner Answer: December Coding Challenge

    December 1, 2012

    Coding for an office visit by a patient with severe rheumatoid arthritis who experiences an adverse reaction to an infliximab infusion and has her IV flushed with saline and pushed with diphenhydramine.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences